Acella Pharmaceuticals recalls Sodium Sulfacetamide Cleanser due to subpotent drug
Acella Pharmaceuticals recalls 6 oz Sodium Sulfacetamide 10% - Sulfur 5% Cleanser (Rx Only) for subpotent drug content. This prescription product may not be as effective as intended.
Lower-risk recall
Subpotent drug
Contact the company
What happened, in plain English
Acella Pharmaceuticals is recalling a prescription cleanser that may have lower-than-stated drug potency. This could mean the product isn't as effective as it should be for medical use. Read more at govinfonow.com/recall/32713-acella-pharmaceuticals-recalls-sodium-sulfacetamide-cleanser-due-to-subpotent-drug.
Source Summary by GovInfoNow · govinfonow.com/recall/32713-acella-pharmaceuticals-recalls-sodium-sulfacetamide-cleanser-due-to-subpotent-drug · Updated August 17, 2026 · FDA enforcement record: FDA #D-0490-2024
Cite this page
“Acella Pharmaceuticals recalls Sodium Sulfacetamide Cleanser due to subpotent drug.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32713-acella-pharmaceuticals-recalls-sodium-sulfacetamide-cleanser-due-to-subpotent-drug. Based on FDA recall #D-0490-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0490-2024%22&limit=1).
Why it’s dangerous
The cleanser contains a subpotent drug, meaning it has less active ingredient than labeled. This could result in the product being less effective for its intended medical use. However, it does not pose a risk of injury or serious harm.
Who’s affected
Prescription users who have the 6 oz bottle with NDC 42192-136-06, manufactured in Alphareta, GA, lot #22085, expiring 08/02/2024. Patients using this cleanser for medical purposes are most at risk.
How to tell if you have this one
Check for the 6 oz bottle labeled 'Sodium Sulfacetamide 10% - Sulfur 5% Cleanser, Rx Only' with NDC 42192-136-06, manufactured in Alphareta, GA, lot #22085, expiring 08/02/2024.
- Brand
Acella Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Verify the product label includes NDC 42192-136-06, lot #22085, and expiration 08/02/2024.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the US and Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 20 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is there a risk of serious injury from this product?
No, the recall states it is a subpotent drug issue, not a safety hazard.
Similar recalls
Other Acella Pharmaceuticals recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0490-2024 (April 24, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0490-2024 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.